Trade PRTA stock anytime, 24x5 in Singapore
Regulated by
Monetary Authority of Singapore (MAS)
Trusted by
400,000+ users
Prothena Corporation plc (PRTA) is trading at US$8.31, up 3.59% today as of Oct 7, 11:07 EDT. The company has a market capitalisation of US$485.13M. Over the past 52 weeks, PRTA has traded between US$7.73 and US$11.80. On Syfe you can trade PRTA with $0 commission and add it to your watchlist.
| Previous close | US$8.02 |
|---|---|
| Market cap | US$485.13M |
| 52-week range | US$7.73 – US$11.80 |
| Volume | 506.22K |
| Exchange | US |
Prothena Corporation plc
Prothena Corp. Plc is a clinical-stage neuroscience company, which engages in the discovery and development of novel therapies to change the course of devastating diseases. The firm’s clinical pipeline includes both wholly owned and partnered programs being developed for the potential treatment of diseases including AL amyloidosis, ATTR amyloidosis, Alzheimer’s disease, Parkinson’s disease and other neurodegenerative diseases. The company was founded in December 1969 and is headquartered in Dublin, Ireland.
Year: 2012
Prothena Corp Public Ltd Insider Bought Shares Worth $465,295, According to a Recent SEC Filing
Jun 5, 5:53 PM · MT Newswires
Prothena Corp Public Ltd Insider Bought Shares Worth $471,300, According to a Recent SEC Filing
Jun 3, 4:50 PM · MT Newswires
Prothena Corporation plc (PRTA) stock is trading at US$8.31, +3.59% from the previous close of US$8.02.
The market cap for Prothena Corporation plc (PRTA) stock is approximately US$485.13M.
The 52-week high for Prothena Corporation plc (PRTA) stock is US$11.80.
The 52-week low for Prothena Corporation plc (PRTA) stock is US$7.73.
Prothena Corporation plc (PRTA) does not currently pay a dividend.
Stay on top of PRTA
Price moves, news and earnings — straight to your inbox.
Snapshot
Popular Stocks in Singapore
